Aclaris Therapeutics (NASDAQ:ACRS) used an H.C. Wainwright inflammatory skin diseases conference fireside chat to outline ...

Sanofi’s TSLP and IL-13 inhibitor has aced a pair of mid-stage studies for respiratory diseases, but missed on a phase 2 ...

Lunsekimig is one of a trio of clinical candidates that Sanofi is developing as successors to its big-selling IL-3 and IL-13 ...

Patients with acute asthma exacerbations who do not suppress eosinophils after a course of oral corticosteroids (OCS) may have slower clinical recovery, according to one study. In some patients with ...

The eosinophilic esophagitis market is witnessing steady growth, primarily driven by the increasing awareness leading to standardized diagnosis and high relapse rates that continue to fuel ongoing ...

Healthy brinchial tube and constricted bronchial tube with asthma CSJ117, formulated as an engineered powder in hard capsules for delivery to the lungs via dry powder inhaler, may be the first inhaled ...

Thymic stromal lymphopoietin (TSLP) is an interleukin-7-like cytokine that is associated with the pathology of atopic dermatitis and asthma. Although the role of this cytokine has been studied in ...

The primary immune cell lineages involved in the initiation and progression of allergic inflammation include dendritic cells (DCs), mast cells, basophils, eosinophils, and type-2 helper T (Th2) cells.

Many children who get a severe skin rash develop asthma months or years later. Doctors call the progression from eczema to breathing problems the atopic march. Now scientists have uncovered what might ...

March 8, 2010 — A genomewide association study has identified a locus on chromosome 5 associated with susceptibility to eosinophilic esophagitis (EoE). The disorder affects 1 person in 10,000 outside ...